Cytokines exert their activities in cell growth and differentiation by binding specific cell membrane receptors. Janus kinases (JAKs) are cytoplasmic protein tyrosine kinases that physically interact with intracellular domains of the cytokine receptors and they play crucial roles in transducing signals triggered by the cytokine-receptor interaction. We have previously shown that conditional activation of JAK through membrane-proximal dimerization confers cytokine-independence on interleukin-3 (IL-3)-dependent Ba/F3 lymphoid cells and that the cytokine-independent proliferation is completely inhibited by dominant negative Ras. In this work, we demonstrate that ectopic expression of a dominant negative form of Stat5, a major signal transducer and activator of transcription ( 
The growth and differentiation of hematopoietic cells are regulated by a set of humoral factors termed cytokines. 1) Cytokines interact with homologous cell membrane receptors that in general do not possess protein tyrosine kinase activity. 2, 3) Recent studies have shown that Janus kinases (JAKs) play crucial roles in cytokine signaling. JAK family proteins, termed Jak1, Jak2, Jak3 and Tyk2, are cytoplasmic protein tyrosine kinases that bind the receptor cytoplasmic regions, and their kinase activity is rapidly stimulated by cytokine treatment. 4) Upon activation, JAKs phosphorylate substrates that include a class of transcriptional factors termed STATs (signal transducers and activator of transcription). The phosphorylated STATs translocate from the cytoplasm to the nucleus, where they initiate the transcription of cytokine-responsive genes. 5, 6) Cytokine-receptor interaction activates multiple cytoplasmic signaling molecules such as Src family protein tyrosine kinases, Ras and phosphatidylinositol (PI)-3 kinase in addition to the JAKs. [7] [8] [9] [10] [11] [12] Concomitant activation of a variety of signal transducers that lie downstream of the cytokine receptors makes it difficult to determine the specific roles of JAKs in cytokine-triggered cell proliferation. To overcome this problem, we modified Tyk2, one of the JAKs, so that it could mimic the receptor-associated JAK by adding a membrane-targeting signal and a chemical dimerizer-dependent dimerization domain. 13) The modified Tyk2 transformed the interleukin (IL)-3-dependent lymphoid Ba/F3 cell into cytokine-independence in a chemical dimerizer-dependent manner. 13, 14) The establishment of the conditional JAK-dependent cells made it possible to study downstream elements of JAKs in mitogenesis without activating other signaling pathways. Indeed we have found that JAK-triggered mitogenesis was inhibited by ectopic expression of dominantnegative Ras. 13) In this work, we demonstrate that, as is the case with dominant-negative Ras, dominant-negative STAT inhibits JAK-mediated proliferation of Ba/F3 cells. Conversely, concomitant activation of ectopic Ras and STAT molecules confers factor independence upon Ba/F3 cells. Our results indicate that Ras and STAT are essential and sufficient downstream components of JAKs in cytokine-dependent cell proliferation.
MATERIALS AND METHODS
Plasmid construction pOPTET-puro and pOPTET-BSD are inducible cDNA expression vectors that possess the TcIP promoter, a chimeric promoter consisting of the tetracycline-regulated promoter and the lac-operator.
15) The promoter activity is negatively and positively regulated by tetracycline and isopropyl thiogalactopyranoside (IPTG), respectively. A cDNA encoding constitutively active c-HaRas v12 was cloned into pOPTET-BSD. A cDNA encoding a dominant negative Stat5 (∆Stat5) was generated by amplifying a cDNA fragment corresponding to the residues 1 to 682 of Stat5b from a mouse T cell cDNA library through polymerase chain reaction and was cloned into pOPTET-puro. A dimerizable Stat5 (Stat5G) was made by ligating a cDNA encoding the dimerization domain derived from bacterial gyrase B in-frame to the 3′ end of human Stat5a cDNA and was cloned into pOPTET-puro. A reporter plasmid was constructed from pGL3-basic vector by connecting the luciferase gene downstream of the Stat5-responsive, β-casein promoter sequences. Cells Ba/F3 is an IL-3-dependent mouse pro-B lymphoid cell line, and 6-1 is a Ba/F3-derived, stable transfectant that constitutively expresses the tetracycline-repressible transactivator and the bacterial lac repressor. 15, 16) Cells were cultured in RPMI1640 medium supplemented with 10% fetal calf serum (FCS) and 20% WEHI-3B-conditioned media (20% WEHI) as a source of IL-3. Generation of stable transfectants Stable transfectants were made from 6-1 cells or SG-15-2 cells, a 6-1-derived transfectant that conditionally expresses a dimerizable Tyk2 (SG-Tyk2), 13) by the electroporation method as described previously. 15) Transfected cells were selected in RPMI1640 supplemented with 10% FCS and 20% WEHI in the presence of 1 µg/ml tetracycline and 1.5 µg/ml puromycin (for pOPTET-puro) or 20 µg/ml blasticidin-S (for pOPTET-BSD). Stable transfectants were single-cell cloned by limiting dilution. Luciferase assay Luciferase assay was performed according to the method described previously. 13) For conditional dimerization of Stat5G, cells were treated with 300 nM courmermycin. Immunoprecipitation and immunoblotting Proteins were induced in the stable transfectants with 5 mM IPTG and were extracted with E1A lysis buffer (ELB). 16) For sequential immunoprecipitation-immunoblotting, cell lysates were first treated with anti-Tyk2 or anti-Stat5 for 3 h. The immune complexes were then collected on protein A-Sepharose beads. Total cell lysates or immunoprecipitates were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred to polyvinyldenedifluoride filters and immunoblotted with appropriate antibodies. Proteins were visualized using the enhanced chemiluminescence detection system (NEN). Antibodies used were anti-Tyk2 (#sc-169; Santa Cruz Biotechnology, Santa Cruz, CA), anti-Stat5 (#sc-835; Santa Cruz Biotechnology), anti-phosphotyrosine (4G10; Upstate Biotechnology), and anti-Ha-Ras (#sc-520; Santa Cruz Biotechnology). Cell growth curve Cells were washed with phosphatebuffered saline to remove tetracycline and then resuspended at a density of 1×10 5 /ml in RPMI1640/10% FCS containing either 1 µg/ml tetracycline or 5 mM IPTG in the absence of IL-3. For dimerization of Stat5G, courmermycin was added to the culture at the final concentration of 300 nM. Viable cell numbers were determined by the trypan blue-dye exclusion assay.
RESULTS
The effect of constitutively active Ras on JAK-mediated cell proliferation In our previous work, we demonstrated that dominant negative c-Ha-Ras, Ras N17 (serine to asparagine mutation at amino acid residue 17), effectively inhibits Tyk2-dependent proliferation of Ba/F3 cells, indicating an essential requirement of Ras activation in JAKmediated mitogenesis.
13) Given this, we decided to address whether constitutive activation of Ras is sufficient to transform Ba/F3 cells so that they have factor-independence. To do so, we generated a conditional expression vector for the constitutively active human c-Ha-Ras, B Ras V12 (glycine to valine mutation at the amino acid residue 12), in which the cDNA expression is inhibited by tetracycline (Tet) and is potently induced by IPTG (pOPTET-BSD-Ras V12 ). Stable transfectant clones were then generated by transfecting pOPTET-BSD-Ras V12 into Ba/F3-derived 6-1 cells. As shown in Fig. 1A , the obtained transfectant clones expressed ectopic Ras V12 in a Tc-IPTG regulated fashion.
The effect of ectopic Ras V12 on cell proliferation was examined by culturing the transfectants in IL-3-free medium. In the absence of IL-3, parental 6-1 cells died within 24 h. Similarly, under a non-induced condition, Ras V12 transfectant cells were dead within 24 h in IL-3-free medium. In contrast, cells expressing Ras V12 did not show any sign of apoptosis by 4 days in culture. It should be noted that the anti-apoptotic effect of active Ras in cytokine-dependent cells has already been reported. 17) To our surprise, the number of Ras [18] [19] [20] we wondered if Stat5 is involved in JAK-dependent proliferation of Ba/F3 cells. To examine this, we generated a cDNA encoding the dominant-negative Stat5 (∆Stat5) and examined its effect on the JAK-mediated mitogenesis.
21) The ∆Stat5 cDNA was inserted into the inducible pOPTET-puro vector, and was stably introduced into SG-15-2 cells, a Ba/F3-derived transfectant that conditionally expresses dimerizable SGTyk2 and hence proliferates in the presence of the chemical dimerizer, courmermycin (CM), in the absence of IL-3.
13) As shown in Fig. 2 , inducible expression of ∆Stat5 in the SG/dSt-5-5 cells ( Fig. 2A) gave rise to strong inhibition of Tyk2-dependent phosphorylation of endogenous Stat5 (Fig. 2B) , indicating that the dominant negative mutant worked in an induction-dependent fashion in the cells. Furthermore, upon ∆Stat5 induction, the transfectant failed to proliferate, despite the activation of Tyk2 by chemical dimerization (Fig. 2C) . We concluded from these observations that Stat5 is another molecular component whose activation is indispensable for JAK-triggered mitogenesis. Generation and expression of conditionally dimerizable Stat-5 in Ba/F3 cells Since STATs are known to be activated upon phosphorylation-dependent dimerization, 5, 6) we suspected that artificial dimerization of STAT with the use of a chemical dimerizer would also activate its transcriptional activity. To this end, we generated a conditionally dimerizable Stat5a in which a chemical dimerization domain derived from bacterial gyrase B (GyrB) was connected to the carboxy-terminal end of Stat5a (Fig. 3A) . The cDNA encoding the Stat5a-GyrB chimera (designated here as Stat5G) was inserted into the pOPTET-puro vector. The resulting plasmid, pOPTET-puro-Stat5G, was then transiently introduced into 6-1 cells. The luciferase reporter assay using β-casein promoter, whose activity is regulated by Stat5, revealed that Stat5G is inducibly expressed in cells by IPTG and its transcriptional activity is potently stimulated by the chemical dimerizer, courmermycin (Fig. 3B) . We concluded from the observation that Stat5G is a conditionally active Stat5, which is activated by the courmycin-mediated dimerization.
The inducible pOPTET-puro-Stat5G plasmid was next introduced into 6-1 cells. Despite extensive screening, we were not able to establish transformants in which the expression of Stat5G is strictly under the control of Tet/ IPTG (Fig. 4A) . However, because the activation of the expressed Stat5G is totally dependent on the chemical dimerizer, we could address the effect of conditional activation of Stat5 on Ba/F3 cell proliferation by employing these transfectants. As 3. To do so, an inducible expression vector for Stat5G (pOPTET-puro-Stat5G) was introduced into the Ras V12 transfectant, Rv-6-10 (see Fig. 1 ), and two independent clones, StG/vR-0-2 and StG/vR-0-3, were established. As we expected, these double stable transfectants inducibly expressed Stat5G and Ras V12 following IPTG treatment (Fig. 5A ). Using one of the transfectants, StG/vR-0-3, we examined the cooperative effect of Stat5 and Ras on cell growth. As demonstrated in Fig. 5B , the inducible expression of Stat5G and Ras V12 gave rise to very weak cell proliferation, most probably due to the activated Ras V12 , as shown in Fig. 1 . In contrast, the activation of Stat5G by chemical dimerization with CM in the presence of Ras V12 induced a strong Ba/F3 cell proliferation comparable to that induced by conditional Tyk2 activation or IL-3 treatment. Again, the presence of a latent time for growth indicates that certain cellular conditioning may be required to initiate cell cycle progression in cells with activated Stat5 and Ras. Essentially the same observation was obtained when another clone, StG/vR-0-2, was examined (data not shown). Our observations thus indicate that concomitant activation of Ras and STAT suffices for cell proliferation.
DISCUSSION
Cytokine-receptor interaction activates multiple cytoplasmic signal transducers in addition to JAKs. The establishment of cells whose proliferation is strictly dependent on the activated JAK provided us with a unique opportunity to study downstream elements of JAKs in mitogenic signaling in the absence of concomitant activation of other signaling pathways that lie downstream of the cytokine receptor.
We have previously shown that JAK, when appropriately activated, is capable of generating sufficient input to promote cell proliferation. 13) This JAK-triggered mitogenesis is blocked by inhibiting either endogenous Ras or STAT activity. However, the single activation of Ras or STAT in Ba/F3 cells is insufficient to induce effective cell proliferation, although constitutively active Ras is capable of preventing apoptosis under cytokine-depleted conditions. In striking contrast, concomitant activation of Ras and STAT in Ba/F3 cells suffices for cytokine-independent proliferation. From these observations, we conclude that Ras and STAT are essential and sufficient downstream components of JAK-triggered mitogenesis. Since JAKs are rapidly activated in response to cytokine-receptor interaction, our results further suggest that the cytokine-induced mitogenic signal bifurcates into Ras and STAT pathways after activation of JAK.
We have shown that p130, a retinoblastoma tumor suppressor protein (pRB) homologue, specifically and actively inhibits cell cycle progression of hematopoietic cells, including Ba/F3. 16, 22) This in turn indicates that p130 must be inactivated when Ba/F3 cells commit to cell cycle progression in response to a mitogenic cytokine. Like pRB, the growth-inhibitory activity of p130 is considered to be regulated by phosphorylation, most likely through G1 cyclin-cyclin dependent kinases (CDKs). 23, 24) Considering these findings together with our findings points to the notion that the Ras and STAT pathways eventually culminate in the regulation of the pRB family of tumor suppressor proteins through G1 cyclin-CDK. Although the molecular mechanisms linking JAK and G1 cyclin-CDK remain obscure, it should be noted that Dtype cyclin was originally identified as a molecule that is induced upon cytokine stimulation in a macrophage cell line. 25) More recently, Ras was reported to be involved in the induction of cyclin D. [26] [27] [28] Hence, through Ras activation, JAK may promote cyclin D-CDK activation.
The observation that the constitutively active Ras V12 is insufficient for cytokine-independent growth implies that effective phosphorylation/inactivation of p130 requires distinct G1 cyclin-CDK(s) in addition to cyclin D-CDK. Work with pRB [29] [30] [31] [32] promotes cyclin E-CDK as an attractive candidate for such a kinase. In contrast to cyclin D, however, regulation of cyclin E expression is poorly understood, although it appears to involve both transcriptional and post-transcriptional mechanisms. [33] [34] [35] Our present work raises the intriguing possibility that STATs may play a role in regulating cyclin E expression. Alternatively, they may control the activities of CDK inhibitors such as p21
Cip1 and p27 Kip1 , both of which neutralize the kinase activity of cyclin E-CDK through physical complex formation. 36) The conditional, JAK-dependent or Ras/STAT-dependent cells established here should provide a powerful tool for identifying the molecular components that link the Ras and STAT pathways with cell cycle regulators.
